The relationship between TRAIL sensitivity and p53 status in GBM has been partly clarified by a study using endogenous and inducible wild-type p53 GBM cell lines, which argues for a protective role of p53 against TRAIL-induced apoptosis [99]. The gene discussed is TNFSF10; the disease is glioblastoma.